Form 8-K - Current report:
SEC Accession No. 0001753926-24-002189
Filing Date
2024-12-30
Accepted
2024-12-30 16:11:45
Documents
23
Period of Report
2024-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084615_8k.htm   iXBRL 8-K 74929
2 EXHIBIT 3.1(I)(A) g084615_ex3-1ia.htm EX-3.1IA 125116
3 EXHIBIT 3.1(I)(B) g084615_ex3-1ib.htm EX-3.1IB 18108
4 EXHIBIT 3.1(I)(C) g084615_ex3-1ic.htm EX-3.1IC 121343
5 EXHIBIT 4.1 g084615_ex4-1.htm EX-4.1 67435
6 EXHIBIT 10.1 g084615_ex10-1.htm EX-4.2 52290
7 EXHIBIT 10.2 g084615_ex10-2.htm EX-10.2 411101
8 EXHIBIT 10.3 g084615_ex10-3.htm EX-10.3 119935
9 GRAPHIC img001_v1.jpg GRAPHIC 11920
10 GRAPHIC img002_v1.jpg GRAPHIC 14432
11 GRAPHIC img003_v1.jpg GRAPHIC 14432
  Complete submission text file 0001753926-24-002189.txt   1399864

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE lipo-20241230.xsd EX-101.SCH 3012
13 XBRL LABEL FILE lipo-20241230_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE lipo-20241230_pre.xml EX-101.PRE 24163
25 EXTRACTED XBRL INSTANCE DOCUMENT g084615_8k_htm.xml XML 3966
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 241589910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)